MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approved Illuccix®...
Read More Details
Finally We wish PressBee provided you with enough information of ( Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America )
Also on site :